secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIPELLA PHARMACEUTICALS INC. (LIPO)
CIK:        0001347242
Form:       8-K/A
Filed at:   2023-02-02T23:59:59+00:00
Accession:  0001753926-23-000103
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipella amends 8-K to correct investor presentation; no new business details
----------------------------------------------------------------------------

- Amendment corrects earlier 8-K that mistakenly included an earlier version of the investor presentation.
- Corrected presentation (Exhibit 99.1) includes additional slides not in the original filing.
- No financial or operational updates disclosed in this amendment; presentation content not excerpted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347242/000175392623000103/0001753926-23-000103-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347242/000175392623000103/g083377_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001753926-23-000103

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer